Epidemiology and clinicopathological characteristics of native kidney disease in children in Flanders, Belgium
- PMID: 36227435
- DOI: 10.1007/s00467-022-05719-7
Epidemiology and clinicopathological characteristics of native kidney disease in children in Flanders, Belgium
Abstract
Background: The Flemish Collaborative Glomerulonephritis Group (FCGG) registry is a population-based kidney biopsy registry that has been including all native kidney biopsies performed in children in Flanders (Belgium), since 2017.
Methods: From 2017 to 2020, 148 pediatric (< 18 years) native kidney biopsies were included. Each biopsy received a histopathological and final nephrological diagnosis, and concordance between both was assessed. Disease chronicity, summarized by the Mayo Clinic Chronicity Score, was determined on 122 biopsies with > 5 glomeruli.
Results: Kidney biopsy rate was high (29.0 biopsies per million children per year), median age was 10.0 years (IQR 5.8-14.7), and boys predominated (56.1% males). A total of 140 biopsies (94.6%) showed a representative pathology result. Glomerular disease was most prevalent, with IgA nephropathy/IgA vasculitis (43 biopsies, 29.1%) and minimal change disease (MCD) (29 biopsies, 19.6%) being the overall most frequent diagnoses. In general, diagnostic concordance was high (80.7%). In Alport syndrome and focal segmental glomerulosclerosis (FSGS), concordance was lower, as the nephrological diagnosis was often determined by results of genetic analysis. Nephrotic syndrome was the most frequent indication for kidney biopsy (31.8%) and was mainly caused by MCD and FSGS. The degree of disease chronicity on kidney biopsies was generally low, although 27.3% of biopsies with a diagnosis of FSGS showed moderate-to-severe chronic damage.
Conclusions: The presented epidemiological findings validate data from previous European registry studies and may inspire kidney biopsy registries worldwide to implement novel features such as clinicopathological concordance and chronicity grading. A higher resolution version of the Graphical abstract is available as Supplementary information.
Keywords: Epidemiology; Kidney biopsy; MCCS; Native kidney; Registry.
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
References
-
- Najafian B, Lusco MA, Alpers CE, Fogo AB (2022) Approach to kidney biopsy: core curriculum 2022. Am J Kidney Dis 80:119–131. https://doi.org/10.1053/j.ajkd.2021.08.024 - DOI - PubMed
-
- Siwy J, Zürbig P, Argiles A, Beige J et al (2017) Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis. Nephrol Dial Transplant 32:2079–2089. https://doi.org/10.1093/ndt/gfw337 - DOI - PubMed
-
- Lodeweyckx N, Wouters K, Ledeganck KJ, Trouet D (2021) Biopsy or biomarker? Children with minimal change disease have a distinct profile of urinary epidermal growth factor. Front Pediatr 9:727954. https://doi.org/10.3389/fped.2021.727954 - DOI - PubMed - PMC
-
- Fiorentino M, Bolignano D, Tesar V, Pisano A et al (2016) Renal biopsy in 2015 - from epidemiology to evidence-based indications. Am J Nephrol 43:1–19. https://doi.org/10.1159/000444026 - DOI - PubMed
-
- Sethi S, D’Agati VD, Nast CC, Fogo AB et al (2017) A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int 91:787–789. https://doi.org/10.1016/j.kint.2017.01.002 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
